• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number VS-402
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thrombus (2101); Injury (2348)
Event Date 07/31/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Patient had a venaseal procedure to treat the left gsv (great saphenous vein).It was reported the vein closed.Follow up study was done six days post procedure, an ultra sound showed the glue was 6 cm from the (superficial femoral artery) and there was a clot extending from the end of the glue to 2 cm into cfv (common femoral vein).No patient injury reported.
 
Manufacturer Narrative
Additional information: the catheter tip was measured and placed 5cm caudal to the saphenous femoral junction prior to initial delivery of adhesive.Patient was prescribed eliquis.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional information: the clot extension has resolved.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Image review: a disc containing sonographic images was received and reviewed.The first two sonograms received were of the patient¿s left gsv.The third sonogram shows a slight amount of sonographic reflective response on the right side of the vessel.Other sonograms show a sonographic reflective response is noted in the centre of the vessel.This reflective response is further studied in the other sonograms provided.The amount of reflective response is an indicator of possible thrombosis formation in the vessel.The remaining sonograms show a reduction in the sonographic reflective response associated with thrombosis in the vessel.The reduction is consistent with the reported event that at a follow-up examination after eight days of pharmaceutical treatment with eliquis that the clot extension had been reduced.The clot extension is now reported to be resolved.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8974206
MDR Text Key156880425
Report Number9612164-2019-03798
Device Sequence Number1
Product Code PJQ
UDI-Device Identifier20643169986262
UDI-Public20643169986262
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
54557
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 01/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/09/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2021
Device Catalogue NumberVS-402
Device Lot Number54557
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/28/2020
Date Device Manufactured02/07/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age65 YR
Patient Weight73
-
-